1. Recommendations for a core set of outcome measures for future phase III clinical trials in knee, hip, and hand osteoarthritis. Consensus development at OMERACT III;Bellamy;J Rheumatol,1997
2. European guidelines for clinical trials of new antirheumatic drugs;Lequesne;Eular Bull,1980
3. ILAR guidelines for testing slow acting drugs in osteoarthritis (SYSADOAs);Lequesne;Rev Esp Rheumatol,1993
4. Outcome measurement in osteoarthritis clinical trials;Bellamy;J Rheumatol,1995
5. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee;Bellamy;J Rheumatol,1988